drugset / Trial / NCT07598890
Phase I Clinical Trial of Adsorbed Tetanus Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This is a randomized, double-blind, parallel-controlled Phase I clinical trial of Adsorbed Tetanus Vaccine. Participants aged ≥18 years will receive one dose of the vaccine to evaluate its safety and immunogenicity.
Timeline
- Start
- 2026-05-21
- Primary completion
- 2026-12-21
- Completion
- 2027-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tetanus Vaccine, Adsorbed | Vaccine | — | Intramuscular |